Literature DB >> 29319481

A critical review of recent clinical practice guidelines for pediatric urinary tract infection.

Michael Chua1,2, Jessica Ming1, Shang-Jen Chang3, Joana Dos Santos1, Niraj Mistry4, Jan Michael Silangcruz2, Mark Bayley5, Martin A Koyle1,6.   

Abstract

INTRODUCTION: Concerns regarding the quality, credibility, and applicability of recently published pediatric urinary tract infection (UTI) clinical practice guidelines have been raised due to the inconsistencies of recommendations between them. We aimed to determine the quality of the recent clinical practice guidelines on pediatric UTI by using the Appraisal of Guidelines Research and Evaluation (AGREE II) instrument, and summarize the standard of care in diagnosis and management of pediatric UTI from the top three clinical practice guidelines.
METHODS: A systematic literature search was performed on medical literature electronic databases and international guideline repository websites. English language-based clinical practice guidelines from 2007-2016 endorsed by any international society or government organization providing recommendations for the management of pediatric UTI were considered. Eligible clinical practice guidelines were independently appraised by six reviewers using the AGREE II tool. Clinical practice guidelines were assessed for standardized domains and summarized for overall quality. Inter-rater reliability was assessed using inter-class coefficient (ICC).
RESULTS: Thirteen clinical practice guidelines were critically reviewed. The Spanish clinical practice guidelines, American Academy of Pediatrics, and National Institute for Health and Clinical Excellence clinical practice guidelines consistently scored high on all AGREE domains (total averaged domain scores 90, 88, and 88, respectively). Among the six reviewers, there was a high degree of inter-rater reliability (average measure ICC 0.938; p<0.0001). There is reasonable consensus among the top three clinical practice guidelines in their major recommendations.
CONCLUSIONS: The clinical practice guidelines from Spain, American Academy of Pediatrics, and National Institute for Health and Clinical Excellence, with their major recommendations being similar, have scored highly on the AGREE II indicators of quality for the clinical practice guidelines development process.

Entities:  

Year:  2017        PMID: 29319481      PMCID: PMC5905538          DOI: 10.5489/cuaj.4796

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  28 in total

Review 1.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

Review 2.  A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms.

Authors:  Michael Erlano Chua; Jonathan Mendoza; Manuel See; Ednalyn Esmena; Dean Aguila; Jan Michael Silangcruz; Buenaventura Jose Reyes; Saturnino Luna; Marcelino Morales
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 3.  Evaluation and management of recurrent urinary tract infections in children: state of the art.

Authors:  Muhammad Awais; Abdul Rehman; Noor Ul-Ain Baloch; Farid Khan; Naseer Khan
Journal:  Expert Rev Anti Infect Ther       Date:  2014-12-09       Impact factor: 5.091

4.  How to decide whether a clinical practice guideline is trustworthy.

Authors:  David F Ransohoff; Michael Pignone; Harold C Sox
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

5.  Quality of reporting and evidence in American Academy of Pediatrics guidelines.

Authors:  Andre Isaac; Michael Saginur; Lisa Hartling; Joan L Robinson
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

6.  KHA-CARI guideline: Diagnosis and treatment of urinary tract infection in children.

Authors:  Steven McTaggart; Margie Danchin; Michael Ditchfield; Ian Hewitt; Joshua Kausman; Sean Kennedy; Peter Trnka; Gabrielle Williams
Journal:  Nephrology (Carlton)       Date:  2015-02       Impact factor: 2.506

7.  New scoring system improves inter-rater reliability of the Neonatal Oral-Motor Assessment Scale.

Authors:  Saakje P da Costa; Nicole Hübl; Nicole Kaufman; Arend F Bos
Journal:  Acta Paediatr       Date:  2016-06-06       Impact factor: 2.299

8.  Implementation of NICE guidance on urinary tract infections in children in primary and secondary care.

Authors:  Caroline Platt; James Larcombe; Jan Dudley; Cliodna McNulty; Jaydip Banerjee; Gita Gyoffry; Katie Pike; Lyda Jadresic
Journal:  Acta Paediatr       Date:  2015-04-02       Impact factor: 2.299

9.  Revised statement on management of urinary tract infections.

Authors:  M Vijayakumar; M Kanitkar; B R Nammalwar; Arvind Bagga
Journal:  Indian Pediatr       Date:  2011-09       Impact factor: 1.411

10.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21
View more
  2 in total

1.  Truth and consequences - The issue with standards and guidelines.

Authors:  Martin A Koyle
Journal:  Can Urol Assoc J       Date:  2018-02-12       Impact factor: 1.862

2.  Cumulative network-meta-analyses, practice guidelines and actual prescriptions of drug treatments for postmenopausal osteoporosis: a study protocol for cumulative network meta-analyses and meta-epidemiological study.

Authors:  Yuki Kataoka; Yan Luo; Anna Chaimani; Akira Onishi; Miho Kimachi; Yasushi Tsujimoto; Mohammad Hassan Murad; Tianjing Li; Andrea Cipriani; Toshi A Furukawa
Journal:  BMJ Open       Date:  2018-12-04       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.